59results about How to "Decreased substances" patented technology

The transfer type inkjet recording method has the intermediate image formation process and the transfer process defined in the specification. The transfer type inkjet recording method includes, in the intermediate image formation process, selecting an intermediate transfer body having a center line surface roughness closest to the center line surface roughness of a recording medium from a plurality of intermediate transfer bodies different from each other in the center line surface roughness, and then an intermediate image is formed on the surface of the selected intermediate transfer body. Moreover, a transfer type inkjet recording which is used for the method is provided.

A porous lithium manganese phosphate-carbon composite material, and a preparation and application thereof. Multiple nano-pores are distributed in the composite material, and the composite material includes a lithium manganese phosphate material and carbon. The method for preparing the porous lithium manganese phosphate-carbon composite material includes the steps of: mixing a porous pyrophosphate material with a doped metal source, a lithium source, phosphate and a carbon source and then drying them to obtain a reaction precursor, and calcining the reaction precursor at a constant temperature under a protective atmosphere to obtain the composite material. The lithium manganese phosphate material contains compounds in a general formula of LiMn_xM_1−xPO₄, and the porous pyrophosphate material contains compounds in a general formula of (Mn_xM_1−x)₂P₂O₇ and 0 wt % to 50 wt % of carbon, where M comprises a transition metal, and 0.6≦x≦1.

The present invention provides an apparatus for processing organic substances, by which performance of processing the organic substances is enhanced. The present invention includes a grinding device for grinding inputted organic substances and a drying device for drying the organic substances grinded by the grinding device.

Provided is an antibacterial aqueous solution comprising a phosphate, a citrate, and a silicate; a method of controlling bacterial contamination and/or growth in food substance; a method of prohibiting the formation of, and/or facilitating the removing of, silicate aggregation on metal article; and a method of reducing phosphate usage in industrial antibacterial process.

The present invention provides an apparatus for processing organic substances such as food and the like, by which time and costs for processing the organic substances are reduced to enhance performance of processing the organic substances. The present invention includes a dewatering means for separating moisture from inputted inorganic substances and a drying means provided to one side of the dewatering means for drying the inorganic substances discharged from the dewatering means.

The invention discloses an injection medicine composition for improving the stability of a quercetin medicine injection preparation, and a preparation method thereof. The injection medicine composition is an injection medicine composition mainly prepared by dissolving salt of quercetin into injection water and adding citric acid and/or sodium citrate as pH regulators to regulate the pH value of medicine liquid. The consumption of the citric acid and/or sodium citrate is 0.1mg to 200.0mg/100ml. The injection medicine composition has the advantages that the pH value of the injection liquid is more stable; the quercetin degradation substances are greatly reduced through being compared with that in the prior art; under the condition of not using other solutizers increasing the clinic application risks, the clarity of the quercetin injection liquid is improved; the problems of small white points, white blocks and solution turbidity of a product of the quercetin injection liquid in the prior art under the condition of long storage time are particularly solved; the visible foreign matter inspection of the product is enabled to conform to the specification of the medicine quality standard; the clinic medication and popularization are convenient.

The invention discloses an injecting medicine composition for improving the stability of a ginsenoside medicine injection and a preparation method thereof. The preparation method mainly comprises the following steps: dissolving salt of ginsenoside in injecting water; adding citric acid and/or sodium citrate to serve as a pH regulator, and regulating the pH value of the medicinal liquid, wherein the dosage of the citric acid and/or sodium citrate is 0.1-200.0mg/100ml. By adopting the preparation method, the pH value of the injection can be stable, the ginsenoside degraded substances are greatly reduced in comparison with that in the prior art, the clarity of ginsenoside injection is improved under a condition that other cosolvent capable of increasing clinical application risks is prevented from being used, and the problems that the ginsenoside injection has small spots, white blocks and turbid solution by adopting the prior art under a condition of long storage period can be especially solved, obviously foreign matter inspection of the injection accords with the specification of medicine quality standard, and clinical medication and popularization can be benefited.

The invention discloses a pharmaceutical composition for injection for improving stability of an illicium henryi medication injection preparation. The pharmaceutical composition for injection is mainly prepared by dissolving extracting solution of illicium henryi in water for injection, adding caffeic acid and/or sodium caffeate to serve as a pH regulator for regulating the pH value of the liquid medicine, wherein the amount of the caffeic acid and/or sodium caffeate is 1-5g/100ml. According to the invention, the pH value of the injection can be stable, illicium henryi degradable substances are greatly reduced compared with that in the prior art, the clarity of the illicium henryi injection is improved under the condition that other cosolvents capable of increasing clinical application risk are not used, particularly the problems that the illicium henryi injection has small white spots and white blocks and turbid in solution when stored for a long time by adopting the products in the prior art are solved, inspection of visible foreign matters in the product can accord with regulations of drug standards, and the pharmaceutical composition is convenient for clinical medication and popularization.

The invention discloses an injection pharmaceutical composition for improving stability of a rhizoma dioscoreae nipponicae drug injection preparation. The injection pharmaceutical composition is mainly prepared by dissolving an extracting solution of rhizoma dioscoreae nipponicae in water, and regulating pH value of medicine liquid with the addition of formic acid and/or sodium formate which serves as a pH regulator, wherein the dosage of the formic acid and/or the sodium formate is 1-3g/100ml. According to the injection pharmaceutical composition disclosed by the invention, the stability of the pH value of the injection (the injection pharmaceutical composition) is enhanced, the content of rhizoma dioscoreae nipponicae degradable substances is greatly reduced in comparison with the prior art, and the clarity of the rhizoma dioscoreae nipponicae injection is improved under the circumstance of avoiding the use of other cosolvents which can increase the risk of clinical application; especially, the problems of the prior art that small white spots, white plaques and solution turbidity easily occur in a finished rhizoma dioscoreae nipponicae injection product can be solved; the obvious foreign matter inspection of the product (the injection pharmaceutical composition) can conform to the specifications of drug quality standard; and the injection pharmaceutical composition is convenient for clinical medication and popularization.